Disease-modifying therapies and infectious risks in multiple sclerosis. Winkelmann A, Loebermann M, Reisinger EC, Hartung H-P, Zettl UK Nat Rev Neurol. 2016 Mar 4. PMID: 26943779. Abstract CommentRecommendBookmarkWatch